Medtronic (MDT) closed the latest trading day at $90.07, indicating a +0.92% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily gain of 0.41%.

A lawsuit against pulse oximeter manufacturers and distributors is starting to create change. But experts say the FDA needs ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to ...

Fortitude Family Office LLC purchased a new stake in Medtronic plc (NYSE:MDT – Free Report) during the third quarter, ...

Galway, Ireland-based Medtronic plc (MDT) develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients. Valued at $116.2 billion by ...

In the most recent trading session, Medtronic (MDT) closed at $90.60, indicating a +0.01% shift from the previous trading day.

Medtronic PLC investors have been content with receiving dividends on their holdings for a few years now. The stock has ...

Beese Fulmer Investment Management Inc. cut its position in Medtronic plc (NYSE:MDT – Free Report) by 24.4% during the third ...

Affera combines mapping technology with a catheter capable of performing radiofrequency and pulsed field ablation.

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

October 24, 2024Both companies also join the newly established World Stroke Organization Advocacy CoalitionAmsterdam, the Netherlands – Royal ...